SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation

被引：0
|
作者：
Yehong Bin
Dong Lan
Wenguang Bao
Haiyan Yang
Shengsheng Zhou
Fengxiang Huang
Man Wang
Zhigang Peng
机构：
[1] the First Affiliated Hospital of Guangxi Medical University,Department of Oncology
来源：
Trials | / 23卷
关键词：
Advanced gastric cancer; Malignant ascites; Intraperitoneal infusion of chemotherapy; First-line chemotherapy; Docetaxel; S-1; Oxaliplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer
    Yoo, Changhoon
    Ryu, Min-Hee
    Na, Young-Soon
    Ryoo, Baek-Yeol
    Lee, Chae-Won
    Maeng, Jeheon
    Kim, Se-Yeon
    Koo, Dong Hoe
    Park, Inkeun
    Kang, Yoon-Koo
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 271 - 278
  • [42] Feasibility Study of S-1 plus Weekly Docetaxel Combined with Concurrent Radiotherapy in Advanced Gastric Cancer Refractory to First-line Chemotherapy
    Fujitani, Kazumasa
    Tsujinaka, Toshimasa
    Yamasaki, Hideya
    Hirao, Motohiro
    Yoshida, Ken
    Kurokawa, Yukinori
    ANTICANCER RESEARCH, 2009, 29 (08) : 3385 - 3391
  • [43] Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study
    Pernot, Simon
    Dubreuil, Olivier
    Aparicio, Thomas
    Le Malicot, Karine
    Tougeron, David
    Lepere, Celine
    Lecaille, Cedric
    Marthey, Lysiane
    Palle, Juliette
    Bachet, Jean-Baptiste
    Zaanan, Aziz
    Taieb, Julien
    BRITISH JOURNAL OF CANCER, 2018, 119 (04) : 424 - 428
  • [44] Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer
    Petrioli, Roberto
    Francini, Edoardo
    Cherri, Sara
    Marrelli, Daniele
    Rovello, Franco
    Fiaschi, Anna Ida
    Miano, Salvatora Tindara
    Savelli, Vinno
    Calomino, Natale
    Farsi, Marco
    Vernillo, Remo
    Francini, Guido
    ANTI-CANCER DRUGS, 2020, 31 (03) : 292 - 297
  • [45] Docetaxel plus S-1 versus docetaxel plus capecitabine as first-line treatment for advanced breast cancer patients: a prospective randomized phase II study
    Abudureheiyimu, Nilupai
    Wu, Yun
    Li, Qing
    Zhang, Pin
    Ma, Fei
    Yuan, Peng
    Luo, Yang
    Fan, Ying
    Chen, Shanshan
    Cai, Ruigang
    Li, Qiao
    Han, Yiqun
    Xu, Hangcheng
    Wang, Yan
    Wang, Jiayu
    JOURNAL OF THE NATIONAL CANCER CENTER, 2023, 3 (02): : 115 - 120
  • [46] Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study)
    Koizumi, W.
    Takiuchi, H.
    Yamada, Y.
    Boku, N.
    Fuse, N.
    Muro, K.
    Komatsu, Y.
    Tsuburaya, A.
    ANNALS OF ONCOLOGY, 2010, 21 (05) : 1001 - 1005
  • [47] Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer
    Liu, Chaoying
    Sun, Qing
    Hang, Xiaosheng
    Zhong, Baoliang
    Wang, Daoyuan
    ANTI-CANCER DRUGS, 2008, 19 (08) : 825 - 831
  • [48] Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study
    Celio, L.
    Sternberg, C. N.
    Labianca, R.
    La Torre, I.
    Amoroso, V.
    Barone, C.
    Pinotti, G.
    Cascinu, S.
    Di Costanzo, F.
    Cetto, G. L.
    Bajetta, E.
    ANNALS OF ONCOLOGY, 2009, 20 (06) : 1062 - 1067
  • [49] Cisplatin, Fluorouracil in Bolus Injection, and Leucovorin in First-Line Therapy for Advanced Gastric Cancer as an Alternative to Protocols With Infusional Fluorouracil
    Coelho, Rafael C.
    Abreu, Pedro D. P.
    Monteiro, Mariana R.
    Stramosk, Ana Paula
    Garces, Alvaro Henrique, I
    Melo, Andreia Cristina
    Graudenz, Marcia S.
    Andrade, Carlos Jose C.
    JOURNAL OF GLOBAL ONCOLOGY, 2019, 5 : 1 - 8
  • [50] Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction
    Peng, Zhi
    Wei, Jia
    Wang, Feng
    Ying, Jieer
    Deng, Yanhong
    Gu, Kangsheng
    Cheng, Ying
    Yuan, Xianglin
    Xiao, Juxiang
    Tai, Yanfei
    Wang, Linna
    Zou, Jianjun
    Zhang, Yanqiao
    Shen, Lin
    CLINICAL CANCER RESEARCH, 2021, 27 (11) : 3069 - 3078
12345